Clinical trial Recruiting at 1 site Interventional Ages 19 to 89

Impact of a DASH diet on kidney stone risk factors

Official title: Effect of a DASH-Style Diet on Urinary Risk Factors for Kidney Stone Disease: A Randomized Controlled Trial (CARDIA Ancillary Study)

Run by University of Alabama at Birmingham · NCT06210009 · Data updated 2026-11-12

This study tests if following a DASH-style diet can lower the risk of kidney stones in people who have already had them.

More Kidney Stone trials

Quick facts

Study typeInterventional
Ages19 Years to 89 Years
SexAll
Enrollment48 (estimated)
SponsorUniversity of Alabama at Birmingham
Academic / other
Locations1 site (Birmingham, Alabama)
StatusRecruiting
StartedJanuary 6, 2025
Main results expectedAugust 31, 2027
Study endsAugust 31, 2027
Registry record updatedJanuary 13, 2026
Trial IDNCT06210009 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates include individuals aged 19-89 from the Birmingham, AL area with a documented history of kidney stone disease.

Probably not a fit

Patients currently on dialysis, kidney transplant recipients, or those with certain metabolic disorders may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This study aims to evaluate how a DASH-style diet influences urinary risk factors associated with kidney stone disease. Participants diagnosed with kidney stones will be randomized to follow either a DASH-style diet or a Western-style diet for one week, with all meals provided by the Bionutrition Unit. The primary goal is to measure changes in 24-hour urine stone risk parameters, establishing a benchmark for future dietary interventions in kidney stone prevention. This is the first controlled study specifically assessing the DASH dietary pattern in this context.

Why it matters

Potential benefit: If successful, this study could provide a dietary intervention that significantly reduces the risk of kidney stone formation.

How similar studies have gone: While dietary interventions for kidney stone prevention have been explored, this specific approach using the DASH diet is novel and has not been previously tested in a controlled setting.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Birmingham, AL area participants of the Coronary Artery Risk Development in Young Adults (CARDIA) study OR patients of the University of Alabama at Birmingham/Kirklin Clinic
* Self-reported, documented, and/or prior imaging-based diagnosis of kidney stone disease
* Age 19-89
* Any sex
* Any race
* Able to provide informed consent
* Willing to perform 24-hour urine collections
* Willing to consume meals prepared by Bionutrition Unit
* No food allergies/intolerance to any of the foods in the study menus
* Willing to stop for 7 days before and during study: Multivitamins and/or Dietary supplements (including calcium and vitamin C)

Exclusion Criteria:

* Dialysis
* Kidney transplant recipient
* Estimated glomerular filtration rate (eGFR) \<60 ml/min/1.73m2 based on historical laboratory measurements
* Renal tubular acidosis
* Current use of acetazolamide, topiramate, or zonisamide
* Primary hyperparathyroidism or history of parathyroidectomy
* Hyperthyroidism
* Sarcoidosis
* Primary hyperoxaluria
* Cystinuria
* Nephrotic syndrome
* Malabsorptive conditions including inflammatory bowel disease or history of malabsorptive surgery (e.g., Roux-en-Y gastric bypass, small bowel resection)
* Urinary retention requiring catheterization
* Urinary diversion
* Pregnancy
* Breastfeeding
* Malignancy treated in the past 12 months other than non-melanoma skin cancer

Where it's running

  • University of Alabama at Birmingham
    Birmingham, Alabama, United States
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.